Jacopo Millul

7PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesMedical molecular engineering of nucleic acids and proteinsMolecular targetsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 09, 2025
Improving Affinity while Reducing Kidney Uptake of CXCR4-Targeting Radioligands Derived from the Endogenous Antagonist EPI-X4.

Raghuvir H Gaonkar, Thibaud Bailly, Jacopo Millul

|Oct 10, 2022
Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors.

Aureliano Zana, Andrea Galbiati, Ettore Gilardoni

|Jul 12, 2022
Mass Spectrometry-Based Method for the Determination of the Biodistribution of Tumor-Targeting Small Molecule-Metal Conjugates.

Ettore Gilardoni, Aureliano Zana, Andrea Galbiati

|Jun 09, 2021
Publisher Correction: Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications.

Nicholas Favalli, Gabriele Bassi, Christian Pellegrino

|Apr 14, 2021
An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications.

Jacopo Millul, Gabriele Bassi, Jacqueline Mock

|Apr 09, 2021
Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications.

Nicholas Favalli, Gabriele Bassi, Christian Pellegrino

Pageof 2

Frequent Collaborators

5 joint publications

Dario Neri

5 joint publications

Samuele Cazzamalli

3 joint publications

Aureliano Zana

2 joint publications

Nicholas Favalli